Drug class
Varicella Vaccines
Varicella vaccines constitute an immunobiologic drug class comprising live, attenuated viral formulations derived from the Oka strain of the varicella-zoster virus. Read more about Varicella Vaccines
6 drugs in this class 3 manufacturers
Drugs in Varicella Vaccines
VARIVAX VACCINE (varicella virus vaccine live/PF)
SHINGRIX (varicella-zoster virus glycoprotein E,rec/AS01B adjuvant/PF)
PROQUAD (PF) (measles, mumps, rubella, and varicella vaccine live/PF)
VARIVAX (PF) (varicella virus vaccine live/PF)
SHINGRIX (varicella-zoster virus glycoprotein E,rec/AS01B adjuvant/PF)
Varicella vaccines constitute an immunobiologic drug class comprising live, attenuated viral formulations derived from the Oka strain of the varicella-zoster virus.
They function by stimulating active immunity through the induction of virus-specific humoral antibodies and cell-mediated immune responses without producing severe clinical disease.
Available as monovalent formulations or in combination with other live virus vaccines, these agents are indicated for the prevention of varicella (chickenpox) infection and its associated severe complications, including secondary bacterial infections, pneumonitis, and encephalitis, in individuals 12 months of age and older.
-
nih.gov
Varicella vaccines constitute an immunobiologic drug class comprising live, attenuated viral formulations derived from the Oka strain of the varicella-zoster virus They function by stimulating active immunity through the induction of virus-specific humoral antibodies and cell-mediated immune responses without producing severe clinical disease
-
fda.gov
They function by stimulating active immunity through the induction of virus-specific humoral antibodies and cell-mediated immune responses without producing severe clinical disease Available as monovalent formulations or in combination with other live virus vaccines, these agents are indicated for the prevention of varicella (chickenpox) infection and its associated severe complications, including secondary bacterial infections, pneumonitis, and encephalitis, in individuals 12 months of age and ...
-
cdc.gov
Available as monovalent formulations or in combination with other live virus vaccines, these agents are indicated for the prevention of varicella (chickenpox) infection and its associated severe complications, including secondary bacterial infections, pneumonitis, and encephalitis, in individuals 12 months of age and older
-
cdc.gov
Available as monovalent formulations or in combination with other live virus vaccines, these agents are indicated for the prevention of varicella (chickenpox) infection and its associated severe complications, including secondary bacterial infections, pneumonitis, and encephalitis, in individuals 12 months of age and older
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.